STRYKER CORP
At today's price, STRYKER CORP (SYK) is priced for today's economics sustained for ~5.7 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Stryker's robotics franchise is compounding through everything: the first quarter set a record for Mako installations in the US and internationally despite a cyberattack that held organic sales growth to 2.4%, and management still reaffirmed full-year guidance of 8% to 9.5% organic growth with adjusted EPS of $14.90 to $15.10. [Source: Q1 2026 earnings call, April 2026] • The price is paying most richly for the Orthopaedics side: today's quote embeds roughly 24% annual operating-profit growth
Is SYK overvalued? See what's priced in →
2,240 institutional managers reported holding SYK in 13F filings for the quarter ended 2026-03-31. Together they hold about 73% of the company; the top 10 hold 35%. 131 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 6.1M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
SYK's share count grew 1.6% over the past five years. It pays a dividend, and has paid one every year in our records (17 and counting), raised 16 years straight; the current rate is $1.56 a share annually. Cash returned over the past three years: $3.41B in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at SYK over the trailing three years. Absence is a fact about the company, not a signal. 23 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
SYK's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-05 | +3.3% | -6.3% |
| 2023-11-04 | +1.5% | +6.9% |
| 2024-02-15 | +6.7% | -6.1% |
| 2024-05-02 | -3.2% | +1.6% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
SYK's latest 8-K filings: 2026-06-26 (items 8.01, 9.01); 2026-05-20 (items 5.02, 9.01); 2026-05-08 (items 5.07); 2026-04-30 (items 2.02, 9.01); 2026-03-23 (items 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: July 11, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.